Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease
| Status: | Completed |
|---|---|
| Conditions: | Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 10/21/2012 |
| Start Date: | December 2011 |
| End Date: | June 2013 |
| Contact: | Roberto P Benzo, M.D., MSc |
| Email: | benzo.roberto@mayo.edu |
| Phone: | 507-284-0561 |
Determining the Relationships Between Self-efficacy for Walking Ability, Gate Speed and Physical Activity in Patients With Chronic Lung Disease
Most patients with chronic lung disease underestimate their actual walking ability due to
low confidence. To better understand the relationships between lung function, self-efficacy
for walking (confidence in ability to walk a defined distance), actual walking ability for
the same distance gait speed and physical activity level-PAL- (total energy
expenditure/resting metabolic rate).
Quality of life, self efficacy for activity questionnaires, physical activity level
measurement, 4-meter gait speed and 6-minute walk distance will be measured.
Inclusion Criteria:
- Men and women 40 years and older
- Diagnosis of any chronic lung disease as evidenced by pulmonary function testing
completed within the prior 12 months
- Able to walk independently and successfully complete the 6-minute walk assessment
Exclusion Criteria:
- Unable to walk without assistance or complete the 6-minute walk assessment
- Patients unable to comprehend and accurately respond to the study questionnaires
either by written or spoken communication
- Patients diagnosed with or treated for a lower respiratory tract infection or COPD
exacerbation within the prior 30 days
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
